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Abstract
Background
Different laboratory methods are used to quantify ferritin concentrations as a marker of iron
status. A systematic review was undertaken to assess the accuracy and comparability of
the most used methods for ferritin detection.
Methods and findings
National and regional databases were searched for prospective, retrospective, sectional,
longitudinal and case-control studies containing the characteristics and performance of at
least one method for serum/plasma ferritin determinations in humans published to date. The
analysis included the comparison between at least 2 methods detailing: sensitivity, preci-
sion, accuracy, predictive values, inter-methods adjustment, and use of international refer-
ence materials. Pooledmethod performance was analyzed for each method and across
methods.
Outcomes
Search strategy identified 11893 records. After de-duplication and screening 252 studies
were assessed, including 187 studies in the qualitative analysis and 148 in the meta-analy-
sis. The most used methods included radiometric, nonradiometric and agglutination assays.
The overall within-run imprecision for the most reported ferritin methods was 6.2±3.4% (CI
5.69±6.70%; n = 171), between-run imprecision 8.9±8.7% (CI 7.44±10.35%; n = 136), and
recovery rate 95.6% (CI 91.5±99.7%; n = 94). The pooled regression coefficient was 0.985
among all methods analyzed, and 0.984 when comparing nonradiometric and radiometric
methods, without statistical differences in ferritin concentration ranging from 2.3 to
1454 μμg/L.
PLOSONE | https://doi.org/10.1371/journal.pone.0196576 May 3, 2018 1 / 24
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Garcia-Casal MN, Peña-Rosas JP,
Urrechaga E, Escanero JF, Huo J, Martinez RX, et
al. (2018) Performance and comparability of
laboratory methods for measuring ferritin
concentrations in human serum or plasma: A
systematic review and meta-analysis. PLoS ONE
13(5): e0196576. https://doi.org/10.1371/journal.
pone.0196576
Editor: Pal Bela Szecsi, Holbæk Hospital,
DENMARK
Received: June 28, 2017
Accepted: April 16, 2018
Published: May 3, 2018
Copyright: © 2018 Garcia-Casal et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: WHO received financial support from
several sources including the International
Micronutrient Malnutrition Prevention and Control
(IMMPaCt) Program, Division of Nutrition, Physical
Activity and Obesity at the US Centers for Disease
Control and Prevention (CDC) (USA), the United
Conclusion
The laboratory methods most used to determine ferritin concentrations have comparable
accuracy and performance. Registered in PROSPERO CRD42016036222.
Introduction
Ferritin is an iron storage protein present in all cells of the organism. A small amount is found
in plasma and serum, which is a reflection of iron stores in healthy individuals [1, 2]. A low
serum ferritin concentration is usually regarded as an indicator of iron depletion, although the
interpretation of normal or high serum ferritin values is challenging in the presence of acute
or chronic inflammatory processes [3, 4], as ferritin is increased in iron overload states and
inflammation [5, 6, 7].
Since ferritin concentration is widely used as marker of iron stores and status, it is impor-
tant to determine if all methods commonly used to assess ferritin concentrations are capable of
detecting and discriminating all possible iron statuses (deficiency, repletion, and overload),
and to assess the comparability of methods across measurement systems, The World Health
Organization (WHO) Expert Committee on Biological Standardization has established inter-
national reference materials to develop tests or to evaluate inter-laboratories performance.
These reference materials for ferritin have been developed for calibrating working/secondary
standards in the routine ongoing assays performed in laboratories and also for evaluating and
standardizing new assays for ferritin quantification. At least three international reference
materials have been developed: 1st (liver), 2nd (spleen) and 3rd (recombinant) [8, 9, 10].
WHO is updating its global guidelines on the use of serum and plasma ferritin thresholds
for diagnosis of iron deficiency and risk of iron overload [11, 12]. While currently WHO rec-
ognizes that ferritin is typically assessed in serum or plasma with enzyme immunoassays after
venous blood collection, there is no specific recommendation on variability among analytical
methods and commutability [13].
The aim of the present review was to analyze the performance and comparability of the
most common laboratory methods used for serum or plasma ferritin concentration determi-
nations to detect iron deficiency, repletion or overload in order to inform decisions on the
need for adjustments in the interpretation of serum or plasma ferritin using different methods.
This was achieved by determining the sensitivity, specificity and predictive value between ferri-
tin methods; assessing the variability of serum or plasma ferritin concentrations using different
laboratory methods of detection; and reviewing the use of international standard materials of
ferritin for calibration purposes and in global public health surveillance.
Methods
Search strategy and selection criteria
A search strategy and structured search was performed and updated in March 27, 2017. The
search strategy for MEDLINE is shown in Table 1. The strategy was adapted to the following
international and regional databases: Cochrane Central Register of Controlled Trials, MED-
LINE, Embase, CINAHL, Science Citation Index, Conference Proceedings Citation Index-Sci-
ence, BIOSIS Previews, ARIF Reviews Database, PROSPERO, Database of Abstracts of
Reviews of Effects (DARE), Cochrane Database of Systematic Review, IBECS, Scielo, Global
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The protocol “Accuracy and comparability of methods for measuring ferritin concentration to
determine iron deficiency, repletion and overload” was registered in PROSPERO International
prospective register of systematic reviews (9 March, 2016 under the number CRD42016036222
(https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016036222)
Prospective, retrospective, sectional, longitudinal and case-control studies containing the
characteristics and performance of at least one method for serum or plasma ferritin determina-
tions for human use were included, as well as studies evaluating the performance of two or
more ferritin methods comparing the same human samples or using international reference
materials. We also considered studies comparing homemade, commercial, automated or single
equipment laboratory methods to determine: method type and sub-type, calibration to inter-
national reference material, limit of detection, reference interval, linearity and interferences.
Table 1. Ovid MEDLINE search strategy.
1 exp Ferritins/ (17454) Note: Lines 1 to 4 are the terms describing the target "ferritin"
2 ferritin.mp. (25116)
3 isoferritin.mp. (328)
4 or/1-3 (25330)
5 exp Enzyme-Linked Immunosorbent Assay/ (131202) Note: Lines 5 to 30 are the terms for capturing the five index
tests
6 Immunoassay/ (23984)
7 immunoassay.tw. (51865)
8 assay.tw. (758672)
9 Radioimmunoassay/ (64971)
10 radioimmunoassay.tw. (47406)
11 RIA.tw. (17348)
12 "Nephelometry and Turbidimetry"/ (6562)
13 turbidmetr.tw. (8)
14 Nephelometr.tw. (2416)
15 Luminescence/ (7001)
16 Luminescent Measurements/ (24362)
17 Luminescen.tw. (12893)
18 chemiluminescen.tw. (17107)
19 spectrometr.tw. (160295)
20 (ELISA or CLIA or ECLIA).tw. (115556)
21 Colorimetry/ (18069)
22 colorimetr.tw. (84)
23 Radiometry/ (28422)
24 radiometr.tw. (3627)
25 quantum dot.tw. (6160)
26 micro array.tw. (790)
27 or/5-26 (1199654)
28 4 and 27 (2646)
29 Ferritins/du [Diagnostic Use] (283)
30 28 or 29 (2922)
31 exp animals/ not humans/ (4109551)
32 30 not 31 (2297)
33 Ferritin bound iron
https://doi.org/10.1371/journal.pone.0196576.t001
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Included studies contained data on participants of any age or gender that reported human
serum or plasma ferritin concentrations in apparently healthy, iron deficient and/or iron over-
loaded populations. Studies from infection/inflammation settings, malaria areas, disaster or
emergency areas, bacterial versus viral infections, acute versus chronic conditions, and data
from diabetic, obese, overweight and/or, insulin-resistant individuals, were also included. Iron
deficiency, iron repletion, and iron overload was defined by the trialists. If not specified, WHO
cut-offs [13] were used.
The studies containing data using international reference materials (especially either of the
WHO reference materials from spleen, liver or recombinant) to calibrate commercial assays,
automated equipment or used in the routine ongoing assays performed in laboratories, were
extracted, sub grouped and recorded in order to register the frequency of use in commercial
assays and automated equipment developments, and in routine laboratory assays and surveys
globally.
The primary outcomes were characteristics and performance indicators of ferritin methods:
type (radiometric, nonradiometric, agglutination), sub-type (EIA, turbidimetric, chemilumi-
nescent, RIA, IRMA), origin of the assay (homemade, commercial), detection equipment (sin-
gle apparatus, automated multiple-analytes detection equipment), sensitivity, specificity,
precision, limit of detection, recovery rate, within-run and between-run imprecision. Data
comparing at least two methods for ferritin determination and extracted correlation coeffi-
cient, coefficient of agreement or Bland-Altman Plot or regression coefficients were also
recorded. The use of international reference materials was also summarized including the ori-
gin, use for calibration while developing the assay or use on a routine basis.
Data collection and analysis
The data retrieved in each search was screened independently by two authors to assess eligibil-
ity. Selected records were independently extracted using data extraction forms tested and
approved by all authors in order to enhance consistency amongst reviewers. Disagreements at
any stage of the eligibility assessment process were resolved through discussion and consulta-
tion with a third author.
The information collected included: general information, sample size, baseline characteris-
tics (iron status, age, sex, race, presence and severity of infection/inflammation), ferritin detec-
tion method(s) used, cutoff points used to define iron deficiency, repletion or overload,
methodological details on ferritin quantification (method(s) used for ferritin determination(s)
and the characteristics of the test already mentioned as outcomes.
We included a PRISMA (preferred reporting items for systematic reviews and meta-analy-
ses) flow-chart of study selection (Fig 1) [14].
The variability of ferritin determinations was assessed by: 1. intrinsic indicators, commonly
used to assess the characteristics of a particular ferritin method (e.g. precision and accuracy);
and 2. comparative indicators between two ferritin methods, such as correlation coefficient.
The intrinsic indicators chosen to characterize the different ferritin methods were within-
run imprecision, between-run imprecision, recovery rate, minimal level of detection (μg/L)
and assay linearity.
The comparative indicators between different ferritin methods included correlation coeffi-
cient (ρ), noise or disturbance term of the regression equation (intercept b) and slope of the
regression equation (m). To assess comparability between methods we compute statistics of
the corresponding linear regression equation parameters and fixed effects meta-analysis of the
correlation. To estimate inter-methods adjustments, a search for laboratory assessment data
was performed. The search included laboratory performance data or reports on internet and
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also directly contacted some laboratories to ask for the possibility of data sharing Bland-Alt-
man plots and/or statistics were extracted if present in the selected studies.
The correlation coefficient between methods was performed by standard correlation fixed-
effects meta-analysis, because the variance depends strongly on the correlation, the last is con-
verted to the Fisher’s z scale, and all analyses were performed using the transformed values. All
statistical analysis was performed using Stata (https://www.jmp.com/en_gb/), MetaXL (http://
www.epigear.com/) and CMA (http://www.comprehensive.com) softwares.
Originally, covariate analysis, development of Summary Receiver Operating Curves
(SROC) and accuracy estimates were planned for the following groups: a) test type or sub-
Fig 1. PRISMA flow-chart of study selection.
https://doi.org/10.1371/journal.pone.0196576.g001
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type: radiometric, nonradiometric, agglutination, other; b) origin of the assay: homemade ver-
sus commercial c) detection equipment/system: single apparatus versus automated detection
equipment; d) assay performance: variability and reproducibility; e) sample matrix: serum,
plasma or erythrocytes; f) age group: infants (less than one year of age), children (two to 11.9
years of age), adolescents (12 to 18.9 years of age), adults (19 years of age or older); g) gender;
h) vulnerability to iron deficiency: infants, women of reproductive age, pregnancy; i) body
mass index (BMI); j) infection/inflammation: malaria area, emergency settings, groups of
patients with inflammatory conditions; k) capability of both-ends detection: iron deficiency,
sufficiency and overload; l) correlation of methods by publication year; m) calibration to inter-
national reference materials. The analyses were performed for the methods and subgroups
with enough available data and included: test type or sub-type (radiometric, nonradiometric,
agglutination); origin of the assay (homemade versus commercial); detection equipment/sys-
tem (single apparatus versus automated detection equipment); assay performance (variability
and reproducibility); limit of detection; calibration to international reference materials.
External laboratory quality assessment data
Data on ferritin measurement precision from laboratory quality assessment programs was
searched and extracted to compare reported between-laboratory means and coefficients of
variation.
Use of international reference materials
For assessing the use of international reference materials, we developed comparative tables for
the most common used methods sub classified as homemade, commercial and automated.
For all analysis, selection of indicators was dictated by data availability and consistency. At
least three studies reporting on a specific indicator detected by the same method type or sub-
type were required to perform meta-analysis estimates. Differences between covariates were
assessed by visual inspection; non-overlapping confidence intervals (CIs) suggested a statisti-
cally significant difference in treatment effect between the subsets.
Results
The PRISMA flow chart of study selection is presented in Fig 1. Eleven thousand eight hundred
ninety three records were obtained from the search strategy depicted in Table 1. From 252 rec-
ords extracted, 187 studies were included in the qualitative analysis [8,10,15–199] and 148 in
the meta-analysis [8,10,15,17,18,22,23,26,28,30–32,34–56,58–64,66–68,72,73,75,77–80,82–
85,87–92,94–98,100–102,106–109,111–116,120–137,139–143,145,146,148–151,153–157,159–
164,166–175,177,179–181,183,184,186–193,195–199]. Many of the studies included in the
meta-analysis provided more than one entry for analysis (some of them compare and analyze
up to 11 methods for ferritin determinations [95,112,139,145,193], resulting in some analysis
including up to 233 entries. In order to summarize the information from each indicator, pooled
estimates were performed for recovery rates and regression coefficients. The characteristics of
the studies included in the meta-analysis are presented in S1 Table, as supplementary material.
Within-run imprecision for method type or sub-type, origin of the assay
and detection equipment
For analysis of within-run imprecisions, the methods more commonly used were 94 nonradio-
metric immunoassays (including 25 enzyme linked immuno sorbent assay (ELISA) and 25
chemiluminescent), 59 radiometric (27 radioimmunoassays (RIA) and 32 immunoradiometric
Accuracy and comparability of ferritin methods
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assay (IRMA)), and 17 based on agglutination (including 13 turbidimetric and 3
nephelometric).
The overall mean within-run imprecision for the most reported ferritin methods was 6.2
±3.4% (CI 5.69–6.70%; n = 171). The method with the highest within-run imprecision was the
enzyme immunoassay with fluorometric detection (8.3±6.3%; CI 3.66–12.95%; n = 7), and the
lowest variation was obtained with nephelometric methods (2.3± 0.4%; CI 1.84–2.70%; n = 3).
Differences were not significant between methods except when comparing with nephelometry,
although the sample size was only 3 data entries (Table 2).
Table 3 shows the mean within-run imprecision when grouping methods by type as nonra-
diometric, radiometric and agglutination; by the origin of the assay (homemade, commercial),
and by detection equipment (single apparatus, automated detection equipment). As reported
before, agglutination methods showed the lowest within-run imprecision (3.8±2.8%; 95% CI
2.5–5.17; n = 17), and radiometric methods the highest (7.1±3.5%; 95% CI 6.16–7.94 n = 59).
Commercial assays had lower within-run imprecision s (5.9±3.3%; 95% CI 5.26–6.45; n = 115)
than homemade kits (6.9±3.5%; 95% CI 5.96–7.82; n = 56), although differences were not sta-
tistically significant. Likewise, automated multiple-analytes detection equipment had lower
within-run imprecision s (5.3±2.7%; 95% CI 4.67–5.86; n = 78), compared to single laboratory
apparatus (7.0±3.7%; 95% CI 6.22–7.72; n = 93), but differences were not significant.
Between-run imprecision for detection method, origin of the assay and
detection equipment
For analysis of between-run imprecision the methods more commonly used were 75 nonra-
diometric immunoassays (including 25 ELISA and 17 chemiluminescent), 47 radiometric (22
Table 2. Within-run imprecision of the methods commonly used for serum or plasma ferritin determinations grouped by method type and sub-type.
Method type and sub-type1 Number of data entries Mean CV3
(%)
STD2
(%)
95% confidence interval
(%)
Lower limit Upper limit
Labelled nonradiometric
EIA 31 5.8 2.5 4.43 6.98
Fluorimetric 7 8.3 6.3 3.66 12.95
ELISA 25 7.5 3.3 6.24 8.80
Chemiluminescent 25 4.8 2.3 3.88 5.72
MEIA 5 4.3 1.8 2.64 5.87
RPIA 1 4.9
Labelled radiometric
RIA 27 7.5 4.0 5.97 8.98
IRMA 32 6.7 3.0 5.65 7.74
Agglutination
Turbidimetric 13 4.3 3.1 2.57 2.94
Nephelometric 3 2.3 0.4 1.84 2.70
LPIA 1 3.1
Other 1 5.4
All 171 6.2 3.4 5.69 6.70
1 EIA: Enzyme immunoassay; ELISA: Enzyme linked immunosorbent assay; MEIA: microparticle enzyme immunoassay; RIA: Radioimmune assay; IRMA:
Immunoradiometric assay; LPIA Latex photometric immunoassay; RPIA: Radial partition immunoassay.
2 Standard deviation.
3 Coefficient of variance.
https://doi.org/10.1371/journal.pone.0196576.t002
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RIA and 25 IRMA), and 14 based on agglutination (including 10 turbidimetric and 3
nephelometric).
The overall mean between-run imprecision for the most reported ferritin methods was 8.9
±8.7% (95% CI 7.44–10.35; n = 136). The method with the highest between-run imprecision
was the nonradiometric immunoassay with fluorometric detection (24.8±41.5%; 95% CI 0.00–
61.21; n = 5), and the lowest variation was obtained with nephelometric methods (4.1± 0.1%;
95% CI 3.99–4.21; n = 3). Variations from chemiluminescent methods (6.9± 2.6%; 95% CI
5.70–8.14; n = 17) were not different from light passage ones. Differences were not significant
between methods as the confidence intervals with the other assays have subtle intersections
(Table 4).
When methods were grouped by type, agglutination methods showed the lowest between-
run imprecision (4.1±2.5%; 95% CI 2.81–5.43; n = 14), and nonradiometric methods the high-
est (9.5±11.0%; 95% CI 7.03–12.03; n = 75), without differences with radiometric ones (9.3
±3.8%; 95% CI 8.21–10.39; n = 47). Between-run imprecisions from commercial assays (9.1
±10.1%; 95% CI 7.03–11.10; n = 95) were not different than from homemade assays (8.5±3.4%;
95% CI 7.45–9.52; n = 41). Automated multiple-analytes detection equipment had between-
run imprecisions (8.9±12.2%; 95% CI 5.89–11.95; n = 62), not statistically different from single
laboratory apparatus (8.9±3.8%; 95% CI 7.99–9.74; n = 74) (Table 5).
Recovery rate for method type and sub-type, origin of the assay and
detection equipment
The pooled recovery rate for all assays evaluated (n = 94) was 95.6% (95% CI 91.5–99.7). When
grouped by method type, agglutination methods showed the lower recoveries (88.1%; 95% CI
80.7–95.4; n = 18) compared to nonradiometric immunoassays that included 12 ELISA and 12
chemiluminescent methods (97.7%; 95% CI 92.1–103.29; n = 54) or to radioactive methods
(103.8%; 95% CI 93.1–114.3; n = 22). There was no difference in recoveries between commer-
cial and homemade assays (94.8%; 95%CI 89.9–99.7; n = 61 vs. 97.6%; 95%CI 89.9–105.2;
Table 3. Within-run imprecision of the methods commonly used for serum or plasma ferritin determinations grouped by method type, by origin of the assay and
by detection equipment.
Number of data entries Mean CV3
(%)
STD1
(%)
95% confidence interval
(%)
Lower limit Upper limit
Method type
Labelled nonradiometric 94 6.1 3.2 5.43 6.74
Labelled radiometric 59 7.1 3.5 6.16 7.94
Agglutination 17 3.8 2.8 2.50 5.17
Other 1 5.4
All 171 6.2 3.4 5.69 6.70
Origin of assay
Commercial 115 5.9 3.3 5.26 6.45
Homemade 56 6.9 3.5 5.96 7.82
Detection equipment
Automated 78 5.3 2.7 4.67 5.86
Single app2 93 7.0 3.7 6.22 7.72
1 Standard deviation.
2 Single apparatus.
3 Coefficient of variance.
https://doi.org/10.1371/journal.pone.0196576.t003
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n = 33, respectively), or between automated multiple-analytes detection equipment and single
laboratory apparatus (94.8%; 95% CI 89.7–99.7; n = 54 vs. 97.4%; 95% CI 90.3–104.5; n = 40,
respectively).
The recovery rates did not changed significantly when data was analyzed by the ferritin
concentration added. In studies spiking ferritin up to 100 μg/L (n = 32), recovery was 92.2%
Table 4. Between-run imprecision of the methods commonly used for serum or plasma ferritin determinations grouped by method type and sub-type.
Method type and sub-type1 Number of data entries Mean CV2
(%)
STD3
(%)
95% confidence interval
(%)
Lower limit Upper limit
Labelled nonradiometric
EIA 24 8.1 3.7 7.21 10.06
Fluorimetric 5 24.8 41.5 0.00 61.21
ELISA 25 10.1 3.6 8.68 11.52
Chemiluminescent 17 6.9 2.6 5. 70 8.14
MEIA 4 5.2 0.4 4.76 5.59
Labelled radiometric
RIA 22 10.0 4.3 8.15 11.76
IRMA 25 8.7 3.3 7.45 10.00
Agglutination
Turbidimetric 10 4.3 3.0 2.41 6.10
Nephelometric 3 4.1 0.1 3.99 4.21
LPIA 1 2.8
All 136 8.9 8.7 7.44 10.35
1 EIA: Enzyme immunoassay; ELISA: Enzyme linked immunosorbent assay; MEIA: microparticle enzyme immunoassay; RIA: Radioimmune assay; IRMA:
Immunoradiometric assay; LPIA Latex photometric immunoassay; RPIA: Radial partition immunoassay.
2 Coefficient of variance.
3 Standard deviation.
https://doi.org/10.1371/journal.pone.0196576.t004
Table 5. Between-run imprecision of the methods commonly used for serum or plasma ferritin determinations grouped by method type, by origin of the assay and
by detection equipment.
Number of data entries Mean CV3
(%)
STD1
(%)
95% confidence interval
(%)
Lower limit Upper limit
Method type
Labelled nonradiometric 75 9.5 11.0 7.03 12.03
Labelled radiometric 47 9.3 3.8 8.21 10.39
Agglutination 14 4.1 2.5 2.81 5.43
All 136 8.9 8.7 7.44 10.35
Origin of assay
Commercial 95 9.1 10.1 7.03 11.10
Homemade 41 8.5 3.4 7.45 9.52
Detection equipment
Automated 62 8.9 12.2 5.89 11.95
Single app2 74 8.9 3.8 7.99 9.74
1 Standard deviation.
2 Single apparatus.
3 Coefficient of variance.
https://doi.org/10.1371/journal.pone.0196576.t005
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(95% CI 85.0–99.3); 97.0% (95% CI 89.7–104.2) for concentrations up to 350 μg/L (n = 30),
and 98.2% (95% CI 83.0–109.5) for concentrations up to 1000 μg/L (n = 25).
Limit of detection
The lowest average levels of detection were found in nonradiometric methods (2.3±4.5μg/L;
n = 72) and agglutination methods (2.6±2.5μg/L; n = 14), compared to radiometric methods
(7.3± 12.5μg/L; n = 47). There was no significant difference in average lowest levels of detec-
tion between commercial and homemade kits (4.2± 9.4μg/L; n = 96 vs. 3.8± 5.5μg/L; n = 38,
respectively), or between automated multiple-analytes detection equipment and single labora-
tory apparatus (2.6± 3.5μg/L; n = 63 vs. 5.5± 10.9μg/L; n = 71, respectively).
The highest average level of detection was found in agglutination methods 1454± 1517μg/L;
n = 14), compared to nonradiometric (1171± 1145μg/L; n = 72), and radiometric methods
(808±1068μg/L; n = 47). There was no significant difference in average highest levels of detec-
tion between commercial and homemade assays (1070± 1025μg/L; n = 96 vs. 1053± 1494μg/L;
n = 38, respectively), or between automated multiple-analytes detection equipment and single
laboratory apparatus (1151± 1068μg/L; n = 63 vs. 989± 1258μg/L; n = 71, respectively).
Assay linearity for method type, origin of the assay and detection
equipment
The most reported maximal ferritin concentrations that maintained assay linearity were 500
and 1000μg/L (11 out of 56 assays). The highest concentration reported to maintain linearity
of the curve was 6000μg/L. The highest concentrations that maintained linearity (2000–
6000μg/L) were no related to a particular method or equipment; they were found with radio-
metric, nonradiometric or homemade assays as well as with agglutination or commercial
assays. Likewise, the lowest linearity concentration reported was 100μg/L, and it was not
related to origin of the assay (commercial or homemade), but the 3 studies that reported such
linearity threshold, were nonradiometric.
Correlation between methods
Table 6 shows a correlation of 0.981 between all methods analyzed. Correlation coefficient was
0.984 when comparing nonradiometric and radiometric methods.
The correlation coefficient was further analyzed at various serum ferritin concentrations.
There were no statistically significant differences in correlation coefficients between methods
when analyzing samples containing up to 300 μg/L (0.94± 0.06; 95% CI 0.928–0.961; n = 44),
up to 800 μg/L (0.99± 0.01; 95% CI 0.984–0.993; n = 42), up to 1500 μg/L (0.98± 0.02; CI
0.972–0.985; n = 45) or even higher concentrations (0.98± 0.03; CI 0.961–0.989; n = 23).
Table 6. Correlation coefficient fixed effects meta-analysis for all methods and comparison between nonradiometric and radiometric methods (pooled estimate
computed using standard Fisher’s Z transform).
Type of Assay Correlation coefficient Estimate 95% confidence interval Number of data entries
Lower limit Upper limit
Nonradiometric vs nonradiometric 0.989 0.988 0.989 107
Nonradiometric vs radiometric 0.984 0.983 0.985 74
Radiometric vs radiometric 0.878 0.869 0.886 51
All 0.981 0.980 0.981 233
https://doi.org/10.1371/journal.pone.0196576.t006
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Intercept (b) and slope (m) of the regression equation
These comparative indicators were found in 85% of the selected articles (115/136), with 218
data entries. As seen in Table 7, intercept values were far from 0 although not significantly dif-
ferent from it for the comparisons between nonradiometric methods or between no radiomet-
ric and radiometric methods, showing a high variability with standard deviations between 8.85
and 20.83 μg/L. For the three comparisons, slopes were close to 1.
Agreement between laboratory methods
It is important to highlight that the use of the correlation, intercept, and slope indicators in
our statistical analysis, only indicated the strength of the relationship or the linearity between
compared methods, not the agreement between them. The most used agreement indicator
Bland-Altman plots [200] and/or statistics, was only reported in seven studies [62, 68, 79, 115,
142, 162, 198] (S2 Table, supplementary material).
A recent study [115] found poor agreement (bias from -11.5 to 44 μg/L and σ higher than
25 μg/L) between ELISA vs microparticle enzyme immunoassay (MEIA) or chemiluminis-
cence. Previously, two other studies [68, 162] found moderate agreement (bias from -8 to
3.7 μg/L and σ from 8.5 to 12 μg/L) between ELISA versus chemiluminescence and radiomet-
ric methods, respectively. Zhang 2015 [198], and Dipalo 2016 [62] found moderate to poor
agreement between chemiluminiscence (bias from 34 to 60 μg/L and σ from 12 to 71 μg/L),
while Molinario 2015 [142] and Gomez 2000 [79] found good agreement between agglutina-
tion and chemiluminescent methods (bias from -6 to -7.9 μg/L and σ from 1.5 to 8 μg/L).
In these seven studies, the authors stated that when ferritin concentrations were below a
certain threshold (75 μg/L for three of the studies) [68, 79, 162], the agreement improved con-
siderably. These results cannot be generalized because of the low number of studies reporting
this indicator, although illustrate the limitations in interchangeability, especially above certain
ferritin concentrations.
Laboratory assessment data
Data on ferritin measurement precision were obtained from four laboratory quality assessment
programs, two reporting on between-laboratory means and coefficients of variation [201, 202],
other [203] on reference range data (lowest limits for ferritin range) and the forth on commut-
ability and deviation from the mean [126]. Based on the highest number of participating labo-
ratories, a report from the XXI Laboratory Quality Assessment Program of the Spanish Society
Table 7. Mean and variance of the regression intercept and slope between nonradiometric and radiometric assays.
Type of Assay Mean intercept ±SD 95% confidence interval Number of data entries
Lower limit Upper limit
Intercept μg/L
Nonradiometric vs nonradiometric 2.72±14.14 -0.070 5.500 99
Nonradiometric vs radiometric -4.14±20.83 -8.919 0.640 73
Radiometric vs radiometric 3.99±8.85 1.487 6.496 48
Slope
Nonradiometric vs nonradiometric 0.93±0.57 0.818 1.041 99
Nonradiometric vs radiometric 0.95±0.32 0.875 1.023 73
Radiometric vs radiometric 1.11±0.45 0.981 1.236 48
https://doi.org/10.1371/journal.pone.0196576.t007
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of Clinical Biochemistry and Molecular Pathology in 2014 was selected for analysis of ferritin
results [202].
One hundred and eighty eight laboratories participated in this round, and most of them
used automated equipment. The methods used for detection in these automated equipment
were immunoenzymatic with different antigen-antibody pairs and detection systems (chemi-
luminiscence, agglutination). The confidence intervals and coefficient of variation calculated
from this report are presented in S3 Table (supplementary material), showing a between-labo-
ratory coefficient of variation from 7.52% to 13.10%, which is in agreement with our findings
of a mean CV of 8.5% for EIA and 6.8% for chemiluminescence.
Use of international reference materials
As shown in S1 Table (supplementary material), some of the studies report calibrating the
assays to WHO or other international reference materials, although calibration data is not pre-
sented in the articles [8,10,18,36,38,45,54,62,78,79,85,95,112,115, 116, 126,131,136,137,139,
140,142,148,155,156,158,162,164,168,171,187,190]. There were no studies reporting the use of
these materials on a laboratory routine basis. Only one study reported results from a serum
pool ‘spiked’ with either the 1st and 2nd international standard for ferritin. Those sera were
measured by 52 laboratories using five automated methods and the recovery of the target val-
ues was calculated. The recovery of the first international reference materials by three of the
methods was between 104 and 129%; and to the second reference material was between 99 and
125%. Authors recommend manufacturers to calibrate their methods against the 3rd interna-
tional standard (recombinant), and to periodically assess their methods relative to this stan-
dard as a means of avoiding assay drift over time [36].
Discussion
Measurement of iron status in the general population is important to determine the prevalence
and distribution of iron deficiency and overload, and thus to decide appropriate interventions,
and to monitor and evaluate the impact and safety of implemented public health programmes.
The selection of a test that reflects real ferritin concentration and has been validated
through the use of reference materials has important implications from the perspective of the
individual and public health pathway. The comparability of results from patients for differen-
tial diagnosis of iron deficiency or risk for iron overload has important implications for clinical
decisions and also the appropriate use of resources. It is important to determine whether a
therapeutic decision and treatment is having the expected effect and is not causing harm,
regardless of the laboratory method used. Likewise, in the planning and evaluation of public
health interventions it is important to determine the iron status of the targeted population as
well as the impact of a nutrition-specific or nutrition-sensitive intervention. If different labora-
tory methods give different results, this may lead to misinterpretation of the effects and lead to
incorrect public health decisions. Additionally, it should be possible to compare data from dif-
ferent surveys performed years apart and performed by different methods.
There are various methods to determine serum, plasma or erythrocyte ferritin concentra-
tion. The vast majority of them are based in antigen-antibody reactions that are detected by
different methods. The detection could be by radioactive counting or by color development
using different enzyme-substrate pairs to measure color development at visible range. Also,
light scattering or turbidimetric measurements have been developed as well as fluorescence
emission. The first reported methods for ferritin determination were radioactive, using radio-
isotopes to label the antigen (IRMA) or the antibody (RIA) [16, 61]. Common colorimetric
methods include peroxidase or glycosidase based color development [177, 204, 205]. Methods
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based in agglutination and light passage could be turbidimetric or nephelometric [35, 206].
More recently, quantum dots, plasma-mass spectrometry, and micro array based technologies
have been developed [207, 208].
Another milestone in the development of methods for ferritin determination was automati-
zation. Radioactive methods started as home made in a few laboratories, followed in few years
by colorimetric tests. Both methodologies were improved and commercialized, making them
widely available. More recently, automated equipment that allow the determination of various
metabolites, including ferritin, have been developed [34, 157, 209]. The detection method for
these equipment vary, but is mainly based on turbidimetry and chemiluminescence.
The evolution of routine medical laboratories is reflected in the different techniques applied
for ferritin determination: the principle of the method used for detection has changed, as well
as the use of automated equipment. Our results show that the methods used in the included
studies and the use of automated or single apparatus equipment for detection, made no differ-
ence for ferritin determinations.
This analysis has limitations. It was not possible to identify a gold standard method for fer-
ritin determinations. This precluded the possibility of comparing ferritin methods against a
reference method or to develop 2x2 tables. Instead, individual method performance and com-
parisons between all available methods that contained consistent data were analyzed.
In most of the included studies there were no details on the characteristics of the human
serum or plasma used to test or validate ferritin assays, and it was not possible to sub classify
studies by iron status (deficiency, repletion or overload), physiological state, age, gender or
inflammatory conditions of the samples used to describe or compare ferritin methods. In fact,
many valuable studies do not report on the methods used to determine ferritin. A recent sys-
tematic review summarized the serum ferritin thresholds recommended by international pro-
fessional organizations associations worldwide to define iron deficiency in different
population groups [210]. There was no mention on the preferred or recommended laboratory
methods or the commutability between them to interpret the results.
Although it was not possible to perform comparisons or meta-analysis, available studies
report the use of WHO or other international reference materials while developing and cali-
brating an assay, but also to improve comparability between methods and assays components
[10, 36, 87, 88, 96, 139, 140, 181]. Studies reporting on commercial, automated equipment
refer the use of international reference materials for calibration while developing an assay [96].
One study on accuracy and precision of seven commercial kits for serum ferritin (3 RIAs and
4 IRMAs), demonstrate that the use of a reference ferritin standard improved the accuracy of
serum ferritin determination, but did not eliminate the variability of the determinations par-
ticularly for high ferritin concentrations [95].
The main challenges identified with the development of this review were related to the vari-
ety of available methods and small practical differences between them, which resulted in a
challenge for categorization of methods. Other important issue was the quality of publications,
especially for automated and commercial assays. In many cases they were only reports or
abstract to scientific meetings, that did not result in a posterior formal, complete publication.
The use of a Diagnostic Test Accuracy (DTA) methods approach to develop this review was
not possible due to the difficulty to unequivocally identify a gold standard method to perform
comparisons.
Regarding statistical analysis, it was not possible to perform meta-analysis of important
indicators such as Bland-Altman statistics (mean differences and corresponding variance),
repeatability, high dose hook effect and carry over due to the limited amount and quality of
data. These limitations also come from the fact that the studies were not trying to compare
accuracies of existing methods, but focused on similarities between two methods that were
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available to them. In fact, more than 98% of the included articles did not study methods agree-
ment or use proper method comparison techniques such as Passing-Bablok regressions [112,
142], Spearman correlations, and concordance methods [62].
The results from this review show that the methods used to determine ferritin are compara-
ble and there is not preferred /recommended laboratory method, although the risk for radioac-
tive contamination and expensive equipment are important drawbacks of RIA and IRMA. For
patient follow-up, public health surveys or evaluations of impact of interventions it is recom-
mended that, once selected, the same ferritin method should be used during the different
stages of the intervention.
International reference materials (e.g. WHO standard) should be used for calibration of all
commercial assays and probably in the regular laboratory practice for periodical assessment of
the reagents and equipment of the routine method used, providing that the reference material
has been shown to be commutable for a particular assay. It is important that reference materi-
als are commutable so the results from samples are equivalent among all procedures, in order
to obtain results traceable to the reference system and without calibration bias among proce-
dures. Laboratories performing ferritin determinations for patient care or for public health
assessments should participate in national or regional quality control surveys.
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